Close Menu

A University of Michigan team describes distinct androgen receptor effects for compounds depending on their DNA response element interactions in prostate cancer. Using a combination of high-throughput drug screening, fluorescent reporter plasmids, transcriptomics, chromatin immunoprecipitation assays, and other approaches, the researchers screened thousands of compounds, searching for those that curbed cancer growth but spared growth by normal cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.